Tag Archives: BioVex Group
Amgen Acquiring BioVex For $1 Billion
Amgen, a human therapeutics company that focuses on advances in recombinant DNA will be acquiring BioVex Group for $1 billion. BioVex is a biotechnology company that works on the treatment of cancer.
(more…)
Categories Amgen, BioVex Group, OncoVex
Leave a comment